Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Treatment of Kratom Dependence With Buprenorphine-Naloxone Maintenance

View through CrossRef
Introduction: Use of the unregulated herbal supplement kratom is on the rise in the United States. We present a case series of 2 patients who developed kratom dependence and withdrawal who were successfully transitioned to buprenorphine-naloxone maintenance. Case Summary: Two patients using kratom to self-treat chronic pain after prescription opioids were discontinued presenting to our clinic with evidence of kratom dependence and withdrawal. On examination, both patients showed signs of mild opioid withdrawal. Both patients were successfully transitioned to buprenorphine-naloxone maintenance via home initiation with control of both their opioid withdrawal and chronic pain. Conclusions: Kratom use is on the rise and with increasing evidence of developing opioid-type dependence due to chronic kratom use. This case series shows that buprenorphine can be used to treat kratom dependence and underlying chronic pain that drives it use.
Ovid Technologies (Wolters Kluwer Health)
Title: Treatment of Kratom Dependence With Buprenorphine-Naloxone Maintenance
Description:
Introduction: Use of the unregulated herbal supplement kratom is on the rise in the United States.
We present a case series of 2 patients who developed kratom dependence and withdrawal who were successfully transitioned to buprenorphine-naloxone maintenance.
Case Summary: Two patients using kratom to self-treat chronic pain after prescription opioids were discontinued presenting to our clinic with evidence of kratom dependence and withdrawal.
On examination, both patients showed signs of mild opioid withdrawal.
Both patients were successfully transitioned to buprenorphine-naloxone maintenance via home initiation with control of both their opioid withdrawal and chronic pain.
Conclusions: Kratom use is on the rise and with increasing evidence of developing opioid-type dependence due to chronic kratom use.
This case series shows that buprenorphine can be used to treat kratom dependence and underlying chronic pain that drives it use.

Related Results

Long-Term Buprenorphine Treatment for Kratom use Disorder: A Case Series
Long-Term Buprenorphine Treatment for Kratom use Disorder: A Case Series
Background: Opioid agonist therapy with buprenorphine is an effective, evidence-based treatment for opioid use disorder. However, there has been increasing use of alternative subst...
Naloxone Knowledge, Carrying, Purchase, and Use
Naloxone Knowledge, Carrying, Purchase, and Use
ImportanceWidespread naloxone access is a key policy response to the opioid crisis. Naloxone availability is typically estimated from pharmacy sales, which exclude naloxone provide...
Naloxone Use for Opioid Reversal in Patients with Sickle Cell Disease
Naloxone Use for Opioid Reversal in Patients with Sickle Cell Disease
Abstract Patients with sickle cell disease (SCD) are known to require increased dosing of drugs including opioids due to differences in renal and hepatic metabolism....
Duration of Methadone and Buprenorphine-Naloxone Treatment
Duration of Methadone and Buprenorphine-Naloxone Treatment
ImportanceFentanyl has spread through the illicit opioid supply in Canada, driving increasing overdose deaths. However, the effectiveness of methadone and buprenorphine-naloxone in...
Sosialisasi Mahasiswa Universitas Tanjungpura Terhadap Isu Kratom (Mitragyna Speciosa) Global
Sosialisasi Mahasiswa Universitas Tanjungpura Terhadap Isu Kratom (Mitragyna Speciosa) Global
Kegiatan pengabdian pada mahasiswa Universitas Tanjungpura (UNTAN) berupa pendampingan dalam memberikan pengetahuan dan keterampilan keamanan konsumsi Kratom agar memenuhi syarat k...
The Effects of Prenatal Buprenorphine Exposure on the Neurobehavioral Development of the Child
The Effects of Prenatal Buprenorphine Exposure on the Neurobehavioral Development of the Child
Background: Current guidelines for pregnant women with substance use disorder advise prenatal maintenance of opioid agonist therapy with either buprenorphine or methadone. Despite ...

Back to Top